DocCheck AG (DE:AJ91)
XETRA:AJ91
Want to see DE:AJ91 full AI Analyst Report?
AJ91 Stock Chart & Stats
€12.60
€0.00(0.00%)
At close: 4:00 PM EST
€12.60
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€10.80 - €15.90
Previous CloseN/A
Volume200.00
Average Volume (3M)1.04K
Market Cap
€76.61M
Enterprise Value€67.31M
Total Cash (Recent Filing)€18.54M
Total Debt (Recent Filing)€4.16M
Price to Earnings (P/E)5.4
Beta0.68
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.36%
Share Statistics
EPS (TTM)1.05
Shares Outstanding5,073,816
10 Day Avg. Volume577
30 Day Avg. Volume1,041
Financial Highlights & Ratios
PEG Ratio12.17
Price to Book (P/B)1.50
Price to Sales (P/S)1.13
P/FCF Ratio23.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a sizeable equity base give DocCheck durable financial flexibility. This supports capital allocation for digital product investment, dividend capacity, and resilience through cyclical advertising spend, reducing refinancing and solvency risk over the medium term.
Sustainable MarginsConsistently healthy EBITDA and net margins indicate structural cost efficiency and pricing power in B2B healthcare services. Such margin sustainability helps absorb revenue swings, fund reinvestment in platform capabilities, and supports long-term profitability even if top-line growth slows.
Specialized Healthcare NetworkOwning a verified healthcare-professional community creates durable competitive advantages: high-quality audience targeting, client stickiness, and differentiated data for campaigns. The secular shift to digital medical communications supports steady structural demand for these services.
Bears Say
Revenue VolatilityUneven revenue and a clear 2025 decline weaken predictability and dilute operating leverage. For a services-led B2B model, this complicates capacity planning, reduces the runway for sustained investment in product development, and raises execution risk over the medium term.
Weakened Free Cash FlowA sharp FCF reduction and operating cash covering only ~half of accounting profit indicate deteriorating cash conversion. Weaker cash generation limits funding for growth, increases dependence on balance-sheet buffers, and constrains shareholder returns or M&A without using reserves.
Normalized Growth Vs Prior PeaksReturns and growth have normalized from exceptional 2020–2021 levels, suggesting market saturation or tougher competitive dynamics. Without meaningful new products or expansion, upside to revenue and ROE is constrained, limiting long-term compounding potential.
DocCheck AG News
AJ91 FAQ
What was DocCheck AG’s price range in the past 12 months?
DocCheck AG lowest stock price was €10.80 and its highest was €15.90 in the past 12 months.
What is DocCheck AG’s market cap?
DocCheck AG’s market cap is €76.61M.
When is DocCheck AG’s upcoming earnings report date?
DocCheck AG’s upcoming earnings report date is Aug 04, 2026 which is in 76 days.
How were DocCheck AG’s earnings last quarter?
DocCheck AG released its earnings results on Feb 06, 2026. The company reported €0.567 earnings per share for the quarter, beating the consensus estimate of N/A by €0.567.
Is DocCheck AG overvalued?
According to Wall Street analysts DocCheck AG’s price is currently Overvalued.
Does DocCheck AG pay dividends?
DocCheck AG pays a Annually dividend of €0.75 which represents an annual dividend yield of 6.36%. See more information on DocCheck AG dividends here
What is DocCheck AG’s EPS estimate?
DocCheck AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DocCheck AG have?
DocCheck AG has 5,073,816 shares outstanding.
What happened to DocCheck AG’s price movement after its last earnings report?
DocCheck AG reported an EPS of €0.567 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of DocCheck AG?
Currently, no hedge funds are holding shares in DE:AJ91
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocCheck AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.71%
12-Months-Change
Fundamentals
Return on Equity
13.28%
Trailing 12-Months
Asset Growth
-8.52%
Trailing 12-Months
Company Description
DocCheck AG
DocCheck AG offers marketing, customer relationship management, and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, and online and e-commerce services for healthcare market players. It also develops and implements communication strategies for new and traditional media on healthcare and business-to-business sectors; and promotes healthcare startups through seed funding. DocCheck AG is based in Cologne, Germany.